The three pharmaceutical companies have agreed to supply Indonesia with vaccines starting in November even though the products are still in the final stage of testing, on grounds that they already received Emergency Use Authorization in a number of countries.
The move was criticized by experts like University of Indonesia epidemiologist Pandu Riono, who criticized the approval of vaccines as hasty, as they have yet to pass clinical tests on their effectiveness against Covid-19 or even if they have any side effects.
(Writer: Ihsanuddin | Editors: Krisiandi, Bayu Galih)
Sources:https://t.me/kompascomupdate, kemudian join. Anda harus install aplikasi Telegram terlebih dulu di ponsel.